FGFR4 Gene Mutation clinical trials at UCSF
1 research study open to eligible people
An FGFR4 gene mutation is a change in the FGFR4 gene that can alter how cells grow. UCSF is studying a new drug in people with liver cancer and other solid tumors with FGFR4 or related pathway changes. The study records safety, side effects, and early tumor responses.
Showing trials for
Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
open to eligible people ages 18 years and up
A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary antitumor activity of TYRA-430 in cancers with FGF/FGFR pathway aberrations, including locally advanced/metastatic hepatocellular carcinoma and other advanced solid tumors.
San Francisco, California and other locations
Last updated: